Camp4 Therapeutics (CAMP) Shares Outstanding (Weighted Average) (2023 - 2026)

Camp4 Therapeutics has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $57.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $57.9 million, up 187.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.9 million (up 187.42% YoY), and the FY2025 annual result was $142.0, down 100.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $57.9 million for Q1 2026 at Camp4 Therapeutics, up from $142.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $57.9 million in Q1 2026 to a low of $142.0 in Q4 2025.
• The 4-year median for Shares Outstanding (Weighted Average) is $503455.0 (2024), against an average of $12.0 million.
• Peak annual rise in Shares Outstanding (Weighted Average) reached 5317.51% in 2025, while the deepest fall reached 100.0% in 2025.
• Camp4 Therapeutics' Shares Outstanding (Weighted Average) stood at $394976.0 in 2023, then soared by 1087.44% to $4.7 million in 2024, then sank by 100.0% to $142.0 in 2025, then jumped by 40791219.72% to $57.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $57.9 million (Q1 2026), $142.0 (Q4 2025), and $27.3 million (Q3 2025), per Business Quant data.